Tech Company Financing Transactions

Invetx Funding Round

On 5/10/2022, Invetx received $60.5 million in Series B investment from Eight Roads, F-Prime Capital and GV.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Boston Pl. 201 Washington St. 3930
Boston, MA 02108
USA

Phone

Undisclosed

Website

www.invetx.com

Email Address

[email protected]

Overview

Invetx is building the world's premier biotechnology platform for protein-based therapeutics in animal health to transform standards of care in veterinary medicine. The Invetx team of highly experienced R&D leaders from both human biotech and animal health is supported by best-in-class biotechnology partners and an extensive network of industry experts and veterinary scientists.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Juergen Horn

        

Chief Scientific Officer

William Brondyk

        

VP - Bus. Development

Colin Giles

        

Browse more venture capital transactions:

Prev: 5/10/2022: Graft venture capital transaction
Next: 5/10/2022: Hannah Life Technologies venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary